Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis mdm2'

Search results for: 'research area apoptosis mdm2'

7 Items

per page
  1. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  2. ARRY 520 trifluoroacetate
    A4458 ARRY 520 trifluoroacetate
    Summary: KSP inhibitor
      Soluble in DMSO
  3. SU 9516
    A4467 SU 9516
    Summary: Cdk2 inhibitor
      Soluble in DMSO
  4. Danusertib (PHA-739358)
    A4116 Danusertib (PHA-739358)
     2 Citation
    Target: Aurora Kinases
    Summary: Pan-aurora kinase inhibitor
      ≥23.75 mg/mL
  5. Narciclasine
    A3642 Narciclasine
    Summary: Modulates the Rho/ROCK/LIM kinase/cofilin pathway
      ≥14.7 mg/mL
  6. LY2857785
    B8002 LY2857785
    Summary: CDK9 inhibitor
  7. 10058-F4
    A1169 10058-F4
    Summary: C-Myc-Max dimerization inhibitor
      ≥24.9 mg/mL

7 Items

per page